BMO Capital Markets (:) has received an average recommendation of “N/A” from the zero research firms that are presently covering the stock, Marketbeat Ratings reports.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by Community Financial News and is owned by of Community Financial News. If you are viewing this news story on another domain, it was copied illegally and republished in violation of US and international trademark & copyright laws. The legal version of this news story can be viewed at https://www.com-unik.info/2017/08/19/zacks-brokerages-expect-fresenius-medical-care-corporation-nysefms-will-post-earnings-of-0-53-per-share-updated-updated-updated.html.
BMO Capital Markets Company Profile
BMO Capital Markets is the investment banking and capital markets arm of Bank of Montreal, aka BMO Financial Group. It serves corporate, institutional, and government clients in North America, providing equity and debt underwriting, corporate lending and project finance, M&A advisory, and equity and debt research.
What are top analysts saying about BMO Capital Markets? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for BMO Capital Markets and related companies.